| 4 | Statement of changes in beneficial owner... | Fulcrum Therapeutics, Inc. | Donnelley Financial Solutions /fa/ | 02/04/2026 | |
| 4 | Statement of changes in beneficial owner... | Oltmans Curtis Gale | Donnelley Financial Solutions /fa/ | 02/04/2026 | |
| 4 | Statement of changes in beneficial owner... | Fulcrum Therapeutics, Inc. | Donnelley Financial Solutions /fa/ | 12/17/2025 | |
| 4 | Statement of changes in beneficial owner... | Oltmans Curtis Gale | Donnelley Financial Solutions /fa/ | 12/17/2025 | |
| 144 | Filing for proposed sale of securities u... | Fulcrum Therapeutics, Inc. | Morgan Stanley Smith Barney Llc Executive Services /fa | 12/15/2025 | |
| 144 | Filing for proposed sale of securities u... | Oltmans Curtis Gale | Morgan Stanley Smith Barney Llc Executive Services /fa | 12/15/2025 | |
| 4 | Statement of changes in beneficial owner... | Fulcrum Therapeutics, Inc. | Donnelley Financial Solutions /fa | 01/28/2025 | |
| 4 | Statement of changes in beneficial owner... | Oltmans Curtis Gale | Donnelley Financial Solutions /fa | 01/28/2025 | |
| 4 | Statement of changes in beneficial owner... | Avenue Therapeutics, Inc. | Toppan Merrill/fa | 09/25/2024 | |
| 4 | Statement of changes in beneficial owner... | Oltmans Curtis Gale | Toppan Merrill/fa | 09/25/2024 | |
| Load More |